| 000 | 00844 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250511200603.0 | ||
| 264 | 0 | _c19911029 | |
| 008 | 199110s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/0140-6736(91)90705-t _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTurner, E | |
| 245 | 0 | 0 |
_aIron in neuroleptic malignant syndrome. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cSep 1991 |
||
| 300 |
_a820-1 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIron _xblood |
| 650 | 0 | 4 |
_aNeuroleptic Malignant Syndrome _xblood |
| 700 | 1 | _aReddy, H | |
| 773 | 0 |
_tLancet (London, England) _gvol. 338 _gno. 8770 _gp. 820-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0140-6736(91)90705-t _zAvailable from publisher's website |
| 999 |
_c1687600 _d1687600 |
||